Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
11
Bearish filings
19
Named actors
13
Disclosed $ (bull / bear)
$8.3M + 6 of unknown size / $434.2M + 1 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-08 | President & Chief Risk Officer Duffy Matthew Paul | sold | $877K | SEC ↗ |
| 2026-10-08 | President & Chief Risk Officer Duffy Matthew Paul | sold | $1.5M | SEC ↗ |
| 2026-10-06 | President & Chief Risk Officer Duffy Matthew Paul | sold | $1.1M | SEC ↗ |
| 2026-10-02 | President & Chief Risk Officer Duffy Matthew Paul | sold | $34K | SEC ↗ |
| 2026-10-02 | President & Chief Risk Officer Duffy Matthew Paul | sold | $1.1M | SEC ↗ |
5 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-10-02 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MATTHEW DUFFY | filed notice to sell | $4.5M | SEC ↗ |
| 2026-09-14 | Director Carlon Jonathan Winant | sold | $1.6M | SEC ↗ |
| 2026-09-14 | Director of Corporate Development (via J.P. Morgan Securities LLC) Jonathan Winant Carlon | filed notice to sell | $1.6M | SEC ↗ |
| 2026-08-14 | 5%+ holder (13G) — increased stake T. Rowe Price Investment Management, Inc. | increased its stake (13D/G amendment) | — | SEC ↗ |
| 2026-08-13 | Chief Financial Officer Steiner James | sold | $1.8M | SEC ↗ |
| 2026-08-12 | Director and Chief Financial Officer (via Merrill Lynch) James Steiner | filed notice to sell | $3.2M | SEC ↗ |
| 2026-08-12 | Chief Financial Officer Steiner James | sold | $1.3M | SEC ↗ |
| 2026-07-29 | 10% Stockholder (via Morgan Stanley & Co. LLC) FTV VII, L.P. | filed notice to sell | $62.0M | SEC ↗ |
| 2026-07-29 | 10% Stockholder (via Morgan Stanley & Co. LLC) BSIV HOLD 101, LP | filed notice to sell | $54.2M | SEC ↗ |
| 2026-06-30 | Institution (13F) SOROS FUND MANAGEMENT LLC | added to a position | $1.3M | — |
| 2026-06-12 | President and Chief Risk Officer Matthew Duffy | adopted a selling plan | — | SEC ↗ |
| 2026-05-19 | 10% owner / other FTV VII, L.P. | sold | $20.8M | SEC ↗ |
| 2026-05-19 | 10% owner / other BSIV Hold 101, LP | sold | $18.2M | SEC ↗ |
| 2026-05-15 | 10% owner / other FTV VII, L.P. | sold | $138.7M | SEC ↗ |
| 2026-05-15 | 10% owner / other BSIV Hold 101, LP | sold | $121.2M | SEC ↗ |
| 2026-05-15 | 5%+ holder (13G) T. Rowe Price Investment Management, Inc. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-03-31 | Institution (13F) Duquesne Family Office LLC | exited a position | $583K | — |
| 2026-03-13 | CEO & Chairman of the Board Burgess Trevor R | bought | $936K | SEC ↗ |
| 2026-02-20 | Director Vostrizansky Michael Warren | bought | $495K | SEC ↗ |
| 2025-12-31 | Institution (13F) SOROS FUND MANAGEMENT LLC | reported a new position | $5.0M | — |